NCT06615635 - Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Squamous Cell CarcinomaAlpha RadiationImmunocompromisedCarcinoma, SquamousSkin CancerBrachytherapy

Interventions

DEVICE

DaRT seeds

Diffusing Alpha emitters Radiation (DaRT) treatment to be delivered through radioactive sources inserted into malignant cutaneous squamous cell carcinoma of Immunocompromised Patients

Trial Locations (11)

13326

Bassett Healthcare, Cooperstown

30308

Emory University, Atlanta

33201

Hollywood Dermatology, Hollywood

33445

Integrity Research Clinical Associates, Boca Raton

Day Star Skin Cancer Center, Poinciana

33848

Palm Beach Dermatology Group, Palm Beach

35234

Banner Health, Gilbert

55905

Mayo Clinic, Rochester

85006

Us Dermatology Parthners, Phoenix

85032

Alliance Dermatology, Phoenix

9112001

Hadassah Medical Center, Jerusalem